Main > ONCOLOGY (**) > Colon Cancer>MET>MSI-H * > Treatment > USA. M. PembrolizuMAb
USA. M. PembrolizuMAb's subsections
(*) EU Approval Date: 2021. 01.26.
(*) USA Approval Date: 2017. 05.23
Company
Mismatch Repair Deficient
MSI-H: MicroSatellite Instability->
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 02.16
TradeMark
TradeMark Web-Site
USA. M. PembrolizuMAb's products
This section has no products